GGTLC1 and influenza: Among 17 adverse events in the control group, there were four of influenza, two of inflammatory symptoms, two of pain, one of hyperesthesia, two of high ALT levels, one of a high AST level, two of high gamma-glutamyl transpeptidase levels, one of a high alkaline phosphatase level, and two of high creatine kinase levels.